Skip to main content Back to Top
Advertisement

MCM 2021 Clinical Feature: Adult and Pediatric Safety Considerations for Lipid Injectable Emulsions

Broadcast Date: November 17, 2022

 

Subscribe on iTune PodcastsListen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

In this featurette from the 2021 Midyear Clinical Meeting our content matter experts provide an overview of the ASPEN Lipid Injectable Emulsion Safety Recommendations and provide considerations and recommendations for prescribing, ordering review, preparation, administration, and monitoring for lipid injectable emulsions.

HOST

Vicki BasalygaVicki Basalyga, PharmD, MAS, BCPS, BCPPS is the Director of Member Relations for the Clinical Specialists and Scientists at ASHP. In addition to her Director role, Vicki assists in clinical policy development as the Secretary for the Council on Therapeutics, serves as a representative for ASHP on numerous national clinical initiatives and works with members to create essential tools and resources for leaders, practitioners and educators.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.